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Background: Day-to-day interactions depend on conversational narrative, and we
examine here the neurobiological basis for difficulty organizing narrative discourse in
patients with Lewy body disorders (LBD).
Method: Narrative organization was examined in 56 non-aphasic LBD patients,
including a non-demented cohort (n = 30) with Parkinson’s disease (PD) or PD-Mild
Cognitive Impairment PD-MCI,) and a cohort with mild dementia (n = 26) including
PD-dementia (PDD) and dementia with Lewy bodies (DLB), with similar age and
education but differing in MMSE (p < 0.001). We used a previously reported procedure
that probes patients’ judgments of the organization of brief, familiar narratives (e.g.,
going fishing, wrapping a present). A subgroup of 24 patients had MRI assessment of
regional gray matter (GM) atrophy and cerebrospinal fluid (CSF) levels of biomarkers for
Alzheimer’s disease (AD) pathology, including beta amyloid (Aβ), total-tau (t-tau), and
phosphorylated-tau (p-tau).
Results: Mildly demented LBD patients had a significant deficit judging narratives
compared to non-demented patients, but this deficit was not correlated with MMSE.
Regression analyses instead related narrative organization to regions of frontal GM
atrophy, and CSF levels of Aβ and t-tau associated with presumed AD pathology in these
frontal regions.
Conclusion: These findings are consistent with the hypothesis that CSF markers of AD
pathology associated with frontal regions play a role in difficulty organizing narratives in
LBD.
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INTRODUCTION
Daily conversations are critical for day-to-day safety and quality of life. Conversations consist of
narratives or a thematically organized description of events and thoughts. Cognitive deficits on
neuropsychological measures have been reported in patients with Parkinson’s disease (PD) and
related disorders (Hessen et al., 2016), but functional deficits such as limited narrative processing
during a conversation are arguably as important since vague and tangential communication can
have a profound impact on safety and quality of life (Kempster et al., 2010; Rosenthal et al., 2010).
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Previous work has shown deficits in non-aphasic PD patients’
narrative expression primarily due to an organizational deficit
(Ash et al., 2011). In the present study, we examined
the neurobiologic basis for difficulty understanding narrative
organization.
PD is primarily characterized by motor features, and current
consensus criteria do not exclude a PD diagnosis when
cognitive impairment is present at the time of motor onset
(Postuma et al., 2015). Over 20% of PD patients have cognitive
difficulties at presentation and 10% meet criteria for mild
cognitive impairment (PD-MCI; Litvan et al., 2012; Weintraub
et al., 2015). Over the course of disease, up to 80% develop
dementia (PDD; Aarsland et al., 2003; Emre et al., 2007).
In dementia with Lewy bodies (DLB), cognitive difficulties
resembling PDD precede motor features or occur within 1
year of motor onset (McKeith et al., 2005). We refer to these
variants collectively as Lewy body disorders (LBD; Toledo et al.,
2016).
Despite varying degrees of cognitive difficulty,
neuropathological studies link LBD to a shared pathology,
the abnormal aggregation of α-synuclein (α-syn) into Lewy
body inclusions (Irwin et al., 2012a; Goedert et al., 2013).
Moreover, many LBD patients have histopathological features
of Alzheimer’s disease (AD) at autopsy, including amyloid-beta
(Aβ) plaques and neurofibrillary tangles composed of tau
(Braak and Braak, 1990; Irwin et al., 2012a). Aβ pathology
has been related to cognitive impairment in LBD, including
amyloid-PET and cerebrospinal fluid (CSF) Aβ1−42 (Montine
et al., 2010; Siderowf et al., 2010; Gomperts et al., 2013;
Bäckström et al., 2015; McMillan and Wolk, 2016). The
relationship between CSF tau and cognition in LBD has been
less clear: Some associate cognitive difficulty with elevated
CSF tau (Hall et al., 2016; Kang et al., 2016), but this is not
universally confirmed (Terrelonge et al., 2016). In a recent
autopsy-based study, we found that AD-related Aβ and tau
pathology are each associated with more rapid clinical decline
and earlier presentation of cognitive difficulties (Irwin et al.,
2017).
Rare studies have related AD pathology in LBD to functional
impairments impacting quality of life. Here, we investigated
how AD biomarkers in LBD are related to narrative processing.
We used a previously-reported procedure that probes familiar
activities such as “going fishing.” In non-aphasic patients with
frontotemporal degeneration (FTD), narrative comprehension is
impaired because of difficulty understanding the organization
of a narrative (Farag et al., 2010; Figure 1), and this has
been linked to dorsolateral and inferior prefrontal areas.
This appeared to be a relatively selective deficit, because
we did not find a similar association in patients with
typical amnestic Alzheimer’s disease (Farag et al., 2010).
These frontal areas are atrophic in LBD (Cordato et al.,
2000; Burton et al., 2004), and Aβ and tau pathology is
found in these frontal regions (Irwin et al., 2012a; Howlett
et al., 2015). Based on these findings, we hypothesized that
narrative organization would be impaired in LBD, related
to frontal atrophy and a CSF profile associated with AD
pathology.
FIGURE 1 | Example of hierarchal structure for the script “going
fishing.” Empirical judgments of an independent cohort of healthy subjects
are used to assess associativity strengths between all pairs of events in a
narrative, and these are used to construct the hierarchical structure depicted
in the figure. Events from the same cluster have a higher associativity strength
than events from different clusters. We identified triplets of overlapping
within-event and between-event clusters, and these did not involve initial or
terminal events. In the figure, consecutive events with a gray background are
within the same cluster, and circled events are from different clusters. Impaired
narrative organization is reflected by difficulty judging the order of
between-cluster events compared to within-cluster events. All probed pairs of
events occur consecutively within a narrative, and thus greater difficulty
judging different-cluster events compared to within-cluster events cannot be
attributed easily to ordering difficulty.
METHODS
Participants
We assessed 56 non-aphasic, native English-speakers with a
clinical syndrome consistent with LBD. Patients were diagnosed
by board-certified neurologists using published consensus
criteria in a weekly consensus conference (Hughes et al., 1992;
McKeith et al., 2005; Emre et al., 2007; Litvan et al., 2012). A
summary of clinical features is provided in Table 1. Aphasia
was excluded by performance on a structured mental status
exam (Libon et al., 2011). We also excluded patients with other
neurodegenerative diseases, other neurologic conditions such
as stroke or hydrocephalus, a primary psychiatric disorder, or
medical conditions causing cognitive difficulty.
To evaluate impaired narrative organization, we subdivided
patients into two groups: A non-demented group [n = 30; mean
(±S.D.) MMSE = 28.6 (±1.6)] composed of 12 patients with
PD-normal cognition (PD-NC) and 18 PD-MCI patients; and
a mildly demented group [n = 26; mean (±S.D.) MMSE =
25.0 (±4.2)] including 14 PDD patients and 12 DLB patients.
We focused on mildly demented patients to select cases that
were most comparable to the non-demented patients while
allowing us to study a broad spectrum of patients with LBD.
Groups were comparable for age and education and by definition,
non-demented and demented LBD patients differed in MMSE
(t = 4.21; p < 0.001) and performance on a verbal measure
delayed memory recall (t = 4.56; p < 0.001; Table 1). Table 1
also shows that groups did not differ in performance on a
confrontation naming test (p > 0.3) or on a letter-guided
category naming fluency measure of executive functioning (p
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TABLE 1 | Mean (±S.D.) demographic and clinical characteristics of Lewy body-related disorder patients.
Group (n) Age
(Years)
Education
(Years)
UPDRS
parts 1/2/3
MMSEa
(Max = 30)
BNT
(Max = 30)
FAS
(#/Min)
PVLT
(Max = 9)
Non-demented (30) 68.7 (6.2) 17.1 (2.3) 1.7/9.6/20.6 28.6 (1.6) 27.2 (2.5) 47.5 (12.8) 6.9 (2.2)
PD (12) 67.4 (6.5) 16.8 (2.8) 0.8/5.3/21.4 29.0 (1.0) 27.3 (2.2) 47.7 (12.0) 7.2 (2.1)
PD-MCI (18) 69.6 (6.0) 17.2 (2.0) 2.0/11.7/20.3 28.4 (2.0) 27.0 (3.4) 47.5 (14.0) 6.6 (2.3)
Demented (26) 71.5 (8.9) 16.0 (2.2) 2.1/8.3/10.8 25.0 (4.2) 25.9 (3.0) 26.3 (12.9) 3.6 (2.1)
PD-Dementia (14) 74.4 (8.5) 15.9 (2.3) 3.0/14.6/24.6 25.1 (2.6) 26.3 (2.9) 27.4 (13.5) 3.7 (2.3)
Dementia with Lewy Bodies (12) 68.2 (8.5) 16.3 (2.3) 3.3/9.8/14.4 24.9 (5.2) 25.5 (3.4) 25.3 (13.3) 3.5 (2.0)
Normal CSF Aβ1−42 (non-demented = 10,
demented = 8)
66.7 (7.8) 16.6 (2.4) 2.2/10.8/22.2 28.3 (1.6) 27.9 (2.0) 39.1 (11.7) 6.1 (2.1)
Low CSF Aβ1−42 (non-demented = 2,
demented = 4)
69.0 (9.0) 14.3 (2.3) 3.5/13.5/27.8 26.7 (1.6) 25.3 (1.7) 37.4 (12.5) 3.3 (1.5)
aANOVAs showed that MMSE differs between non-demented patients and demented patients (p < 0.001) and between amyloid-positive and amyloid-negative groups (p = 0.046).
MMSE was not available in two non-demented patients and six demented patients, and all of these patients were in the amyloid-negative group. BNT, Boston Naming Test. FAS,
letter-guided category naming fluency of each letter (i.e., F, A, and S) for 1 min. PVLT, Philadelphia Verbal Learning Test delayed recall.
> 0.1). Twenty-four patients (12 non-demented, 12 demented,
matched demographically with their respected groups, all p >
0.1) also underwent CSF sampling and analysis andMRI. Table 1
also shows that groups with low Aβ1−42 and normal Aβ1−42
CSF levels were matched for age and education, and differed
marginally in MMSE (t = 2.16; p < 0.05). Some of these
patients contributed to a previous report where we described
latency performance rather than accuracy (see below; Ash et al.,
2012). Fifteen community-dwelling healthy seniors served as a
normal cognitive reference group for LBD patients. All subjects
participated in an informed consent procedure approved by the
University of Pennsylvania Institutional Review Board.
Cognitive Materials
Using a reported procedure (Farag et al., 2010), we probed
22 narratives describing familiar activities, each containing six
routine events. Briefly, a cohort of young control subjects
were presented with the six events of each script typed on
separate pieces paper, and asked to order the events. The
subjects then were asked to cluster the events of each script into
closely associated clusters. Based on these clusters, we derived
associativity strengths between pairs of events and formed these
into a hierarchical tree. Figure 1 illustrates an example of an
empirically-derived, hierarchically-organized tree structure for
the narrative “going fishing.” To examine narrative organization,
we identified event triplets where one consecutive pair of events
came from the same hierarchical cluster (within-cluster, gray
events in Figure 1), and another consecutive pair (where one
event was shared with the within-cluster pair) came from two
different hierarchical clusters (different-cluster, circled events in
Figure 1). Greater difficulty judging pairs of consecutive events
from different clusters compared to the same cluster would be
consistent with a deficit understanding narrative organization.
We generated four types of experimental stimuli in a
counterbalanced 2 × 2 design presented in a pseudo-random
order. Each stimulus was comprised of two events (e.g., “open
can of worms,” “place worm on hook”). The experimental design
included a factor for Narrative Organization (within-cluster,
different-cluster) and a factor for Order (correct order, incorrect
order). We presented one instance of each type of stimulus pair
from each of the 22 scripts, resulting in 88 stimuli. There was
no difference in overall ordering accuracy across LBD groups
[F(3, 52) = 2.12; p > 0.1], and we report below the critical
judgments of correctly-ordered adjacent events from the same
cluster compared to correctly-ordered adjacent events from
different clusters. We also presented filler material composed
of 44 correctly-ordered pairs of non-adjacent different-cluster
events from these triplets and incorrectly-ordered pairs of these
non-adjacent different-cluster events. For each stimulus, the
narrative title was presented at the top of a computer screen and
a pair of events was displayed below this. Participants took as
much time as needed to judge event order accuracy for the named
script. Responses were recorded by pressing one of two buttons
on the computer keyboard. Prior to the experiment, participants
were given a practice run with six judgments, and incorrect
answers were explained by the experimenter. All participants
understood instructions.
CSF Analyses
Methods for acquiring and storing CSF Aβ1−42, t-tau, and
p-tau were described previously (Shaw et al., 2009; Irwin
et al., 2012b). Briefly, CSF samples were obtained by lumbar
puncture using a 22-gauge spinal needle as described in the
Alzheimer’s Disease Neuroimaging Initiative (ADNI) procedures
manual (http://www.adni-info.org/). CSF was divided into
aliquots (0.25 mL) and stored in bar code-labeled polypropylene
vials at −80◦C. Aβ1−42 was measured using the multiplex
xMAP Luminex platform (Luminex Corp, Austin, TX) with
Innogenetics (INNO-BIA AlzBio3; Ghent, Belgium; for research
use only reagents) immunoassay kit-based reagents (Shaw et al.,
2009). Full details for the combination of immunoassay reagents
and analytical platform employed in the present study are
explained elsewhere (Irwin et al., 2012b). Reliability studies
(http://www.adni-info.org) show high reproducibility for this
biomarker, with <10% variance. In line with previous studies
(Shaw et al., 2009), CSF Aβ1−42 was analyzed as a binary measure
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employing a level of ≤192 pg/mL as a cutoff, resulting in two
subgroups of patients: low Aβ1−42 patients (≤192 pg/mL, n =
11) with CSF levels that are associated with AD pathology (Shaw
et al., 2009; Irwin et al., 2012b), and normal Aβ1−42 patients
(>192 pg/mL, n= 26) with CSF levels that are not associated with
AD pathology. The clinical features associated with these groups
are summarized in Table 1. CSF t-tau and p-tau were assessed
parametrically with correlation and linear regression, and the
model included age, MMSE, and CSF Aβ.
Statistical Analyses
Behavioral analyses used analysis of variance (ANOVA) with a
group X narrative organization design, with follow-up t-tests
and correlations to help interpret the results. We accepted as
significant only statistical results exceeding p < 0.05. Linear
regressions were used to relate behavioral performance to CSF
analyte levels.
Imaging Analyses
Methods for acquisition and preliminary analysis ofMRI imaging
were described previously (Tustison et al., 2014; McMillan and
Wolk, 2016). Briefly, high-resolution volumetric T1-weighted
MRI was obtained within 9 months of behavioral testing. Imaged
patients matched the overall group in age, education, MMSE and
gender (all p > 0.6). Exclusion from MRI was related to health
and safety (e.g., metallic implants, shrapnel, claustrophobia),
intercurrent medical illness, transportation difficulty, and lack
of interest in participating in an imaging study. MRI volumes
were acquired using an MPRAGE sequence from a SIEMENS
3.0T Trio scanner with an 8-channel head coil and the following
acquisition parameters: repetition time = 1620 ms; echo time
= 3.87 ms; slice thickness = 1.0 mm; flip angle = 15◦; matrix
= 192 × 256, and in-plane resolution = 1.0 × 1.0 mm, or
using a GE 1.5T scanner with 1.2-mm slice thickness and
a 144 × 256 matrix. Images from both scanners were de-
formed into a standard local template space with a 1-mm3
resolution. Whole-brain MRI volumes were preprocessed using
an established pipeline with Advanced Normalization Tools
(Tustison et al., 2014). Briefly, ANTs performs a diffeomorphic
deformation of each individual dataset into a standard local
template space. Template-based priors guide GM segmentation
and compute GM probability, reflecting a quantitative measure
of GM density. Resulting images are warped into MNI space,
smoothed using a 4 mm full-width half-maximum Gaussian
kernel and downsampled to 2 mm resolution. Permutation-
based imaging analyses were performed with threshold-free
cluster enhancement (TFCE; Smith and Nichols, 2009) using the
randomize tool in FSL (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki).
In the core analysis, GM density was compared in LBD
patients relative to healthy seniors (an independent group of 32
healthy seniors with imaging who matched the patient group for
education, age, and gender; all p > 0.2) using a permutation-
based (n = 10,000 permutations) t-test with the randomize
tool in FSL (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki). Analysis was
restricted to voxels containing high probability GM (>0.3) using
an explicit mask generated from the average GM probability
map of all participants. We report clusters (minimum of 50
adjacent voxels) that survived a p < 0.05 threshold-free cluster
enhancement (TFCE; Smith and Nichols, 2009) threshold with
family-wise error (FWE) correction after covarying for age and
scanner used to collect data.
To evaluate the relationship of narrative judgments with GM
atrophy and CSF biomarkers, we performed three region-of-
interest (ROI) analyses. These hypothesized ROIs were defined
using a prior study relating narrative organization performance
to GM atrophy in AD or FTD (six ROIs) and to fMRI in healthy
adults (two ROIs; Farag et al., 2010). For each ROI, we generated
a 10 mm radius sphere around each peak voxel (see Table 2 for
peak locations). In each experimental regression investigating
the relationship between narrative judgments and imaging,
we performed permutation-based (n = 10,000 permutations)
analyses at p < 0.05 and k = 50 in analyses illustrated in
Figures 2A,C, and k= 15 in Figure 2B, using the randomize tool
in FSL, including covariates for age at time of MRI and scanner,
and one-tailed statistical tests were used because of our a priori
hypotheses.
In the first ROI analysis, we assessed how LBD narrative
performance relates to GM atrophy in the hypothesized ROIs
using univariate regressions relating mean GM density in each
ROI to a behavioral difference score (different-cluster minus
within-cluster judgments). This analysis and the regressions
below used the randomize tool in FSL with 10,000 permutations
at p < 0.05 with k = 50. Here and below, we covaried for age at
time of MRI and scanner.
In the second analysis, we assessed the role of Aβ in narrative
judgments. A t-test identified regions of GM atrophy in LBD
with low CSF Aβ relative to LBD with normal CSF Aβ, using an
explicit mask consisting of regions associated with GM atrophy
in all LBD relative to controls, with k = 15. We evaluated the
overlap between regions associated with low CSF Aβ and the
hypothesized ROIs.
Third, we examined the relationship between areas of
GM density associated with elevated CSF tau and narrative
organization difficulty. We identified areas of GM atrophy
significantly related to elevated CSF t-tau or p-tau using
regression analyses with k = 50, masked by areas of GM atrophy
in all LBD patients compared to controls. We then identified
areas of GM atrophy associated with CSF tau that overlapped
with the hypothesized ROIs.
RESULTS
Behavioral Results
AnANOVAwith a group (non-demented, demented) X narrative
organization (within-cluster, different-cluster) design revealed a
significantmain effect for narrative organization [F(1, 54) = 17.60;
p < 0.001] and a significant group X narrative organization
interaction effect [F(1, 54) = 11.76; p = 0.001]. For judgments
of different-cluster events, demented patients [mean (±S.D.)
% correct = 82.69 (±15.0)] performed worse than non-
demented patients [mean (±S.D.) % correct = 92.27 (±13.7)]
[t(54) = 2.49; p = 0.006]. By comparison, for judgments of
within-cluster events, non-demented patients [mean (±S.D.)
% correct = 93.18 (±17.3)] and demented patients [mean
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TABLE 2 | Gray matter atrophy in lewy body spectrum disorders, and relationship of gray matter atrophy in regions critical for narrative judgments to
cerebrospinal fluid analytes.
Beta weight r-square p-value Peak coordinate
x y z
PEAK COORDINATES OF SPHERES RELATED TO NARRATIVE ORGANIZATION, AND REGRESSIONS RELATING THESE SPHERES TO PERFORMANCE
ON DIFFERENT-CLUSTER JUDGMENTSa
Left dorsolateral prefrontal 0.06361 0.121 0.047 −26 29 28
Left inferior frontal (fMRI) 0.1028 0.251 0.005 −52 12 −1
Right inferior frontal (fMRI) 0.05925 0.124 0.040 54 31 −2
Right inferolateral frontal 0.06695 0.151 0.027 42 48 −10
Left anterolateral temporal 0.05709 0.159 0.030 −46 2 −45
Left medial parietal 0.1123 0.276 0.004 −10 −55 53
Left inferior frontal 0.05624 0.112 0.055 −36 9 18
Right superior frontal 0.05592 0.093 0.074 30 32 46
Color Aβ overlapb (voxels) Aβ overlapb (%)
OVERLAP OF SPHERES RELATED TO NARRATIVE ORGANIZATION WITH GRAY MATTER ATROPHY RELATED TO LOW CSF Aβ
Left dorsolateral prefrontal Light blue 12 16
Left inferior frontal (fMRI) Purple 22 30
Right inferior frontal (fMRI) Light green 17 22
Right inferolateral frontal Dark green 13 17
Left anterolateral temporal Middle blue 0 0
Left medial parietal Middle green 0 0
Left inferior frontal Green-blue 12 16
Right superior frontal Yellow 15 19
Color Regression overlap (voxels) Regression overlap (%)
OVERLAP OF SPHERES RELATED TO NARRATIVE ORGANIZATION WITH GRAY MATTER ATROPHY RELATED TO TOTAL TAU
Left dorsolateral prefrontal Light blue 21 27
Left inferior frontal (fMRI) Purple 0 0
Right inferior frontal (fMRI) Light green 0 0
Right inferolateral frontal Dark green 0 0
Left anterolateral temporal Middle blue 18 23
Left medial parietal Middle green 0 0
Left inferior frontal Green-blue 0 0
Right superior frontal Yellow 4 5
aTwo peaks were taken from fMRI activations during task performance in healthy controls, and six regions from regressions of task performance with patient gray matter atrophy from
Farag et al. (2010).
bOverlap refers to the number of shared voxels and the % shared volume that regressions in PD spectrum disorders overlap with the 10 mm spheres created around peak coordinates
associated with narrative structure judgments in Farag et al. (2010).
(±S.D.) % correct = 91.78 (±10.2)] were equally accurate.
Demented patients had greater difficulty with different-cluster
events compared to their own judgments of within-cluster events
[t(25) = 4.14; p < 0.001]. We also examined each individual’s
difference score for within-cluster and different-cluster events,
and found a greater difference in demented compared to non-
demented patients [t(54) = 3.43; p = 0.001]. Although groups
differed in MMSE, we did not find a correlation between
MMSE and the difference score [r(20) = −0.14; ns], nor
between MMSE and different-cluster judgments [r(20) = 0.53;
ns]. These findings indicated that LBD patients with dementia
have relative difficulty understanding narrative organization.
Since there was a poor correlation between performance
and overall dementia severity, we examined other factors
that may be contributing to difficulty understanding narrative
organization.
CSF Analyses
An ANOVA with a group (low-Aβ, normal-Aβ) X narrative
organization (within-cluster, different-cluster) design found a
significantmain effect for narrative organization [F(1, 22) = 15.88;
p = 0.001] and a significant group X narrative organization
interaction [F(1, 22) = 8.35; p= 0.009]. The interaction remained
significant after covarying for MMSE [F(1, 19) = 5.62; p =
0.029]. LBD with low Aβ had greater difficulty judging different-
cluster events compared to their own judgments of within-cluster
events [t(5) = 3.21; p = 0.024], and the difference score for
within-cluster and different-cluster judgments was significantly
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FIGURE 2 | Gray matter atrophy in Lewy body spectrum disorders, and relationship of gray matter atrophy in regions critical for narrative judgments to
cerebrospinal fluid analytes. Panel (A): Significant gray matter atrophy in Lewy body spectrum disorder patients compared to controls. Green blobs indicate gray
matter atrophy at p < 0.05 FWE-corrected. Coronal slice y-axis is indicated above each image and illustrated on the sagittal image at the right. Panel (B): Regions of
significant gray matter atrophy in Lewy body spectrum disorder patients with low CSF Aβ compared to normal CSF Aβ (red blobs), and overlap of these areas with
hypothesized regions of interest related to narrative organization from Farag et al. (2010; see color code in Table 2). Panel (C): Gray matter regions significantly related
to CSF total-tau (blue blobs), and overlap of these areas with regions of interest related to narrative organization from Farag et al. (2010; see color code in Table 2).
greater in patients with low-Aβ compared to normal-Aβ [t(22) =
2.89; p = 0.009]. Although analyses of Aβ are typically treated
dichotomously, we performed exploratory analyses examining
the impact of Aβ on narrative organization that treat Aβ as a
continuous variable because of the small number of abnormal
Aβ values. Regression confirmed that different-cluster judgments
are associated with CSF Aβ level [F(1, 28) = 5.16; p = 0.031],
accounting for 15.6% of the variance (β = 0.394). Here, we
found a correlation indicating that accuracy for different-cluster
judgments decreased as CSF Aβ levels decreased [r(28) = 0.39;
p= 0.031].
Different-cluster judgments were correlated with CSF t-
tau levels [r(28) = −0.59; p < 0.001]. Regression showed
that different-cluster judgments are associated with CSF t-tau
level [F(1, 28) = 14.93; p < 0.001], accounting for 34.8% of
the variance (β = −0.590). Age, MMSE, and CSF Aβ level
did not contribute. Accuracy judging different-cluster events
decreased as CSF t-tau levels increased [r(24) = −0.56; p =
0.004]. Only the result for t-tau survived in a regression model
that included CSF levels of both t-tau and Aβ. Regression
investigating the relationship between CSF p-tau level and
different-cluster judgments was only marginal [F(1, 29) = 3.61;
p = 0.068]. These findings suggest that judgments of narrative
organization may be associated with AD-related biomarkers in
LBD CSF.
Imaging Analyses
GM atrophy in LBD is illustrated in Figure 2A, and Table 2 lists
the anatomic location of peaks within atrophic regions. Table 3
lists the number of atrophic voxels in all regions. Significant
atrophy relative to controls (p < 0.05, FWE-corrected) was most
evident in frontal regions bilaterally, but significant atrophy was
also seen in parietal and temporal regions.
Table 2 summarizes areas where regression indicates a
significant relationship between the critical different-cluster
judgments and significant atrophy. Implicated regions included
left inferior frontal, right inferior frontal, left dorsolateral frontal,
and left medial parietal GM. These findings suggest that narrative
organization may be related to GM atrophy in LBD.
We also contrasted atrophy in patients with low-Aβ compared
to normal-Aβ, illustrated in Figure 2B. Table 3 summarizes the
overlap between atrophic voxels and voxels associated with
low-Aβ. This analysis identified regions of significant atrophy
associated with low-Aβ in dorsolateral and inferior frontal
regions bilaterally, as well as temporal, parietal, and striatal
regions. Figure 2B and Table 2 show the overlap between
regions associated with low-Aβ and ROIs implicated in narrative
organization. Regions with significant GM atrophy associated
with low Aβ and that are also related to narrative judgments
included left dorsolateral frontal, left inferior frontal, and right
inferior frontal areas.
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TABLE 3 | Anatomic distribution of the numbers of voxels in each MRI region of each MRI analysis in the oasis-30 label set.
Anatomical region CSF patients vs. controls Low Aβ voxel overlap t-tau voxel overlap
Left Right Left Right Left Right
Accumbens area 2 0 6 0 0 0
Amygdala 10 25 3 11 0 0
Brain stem 293 0 122
Caudate 0 30 17 0 160 97
Hippocampus 92 176 16 85 0 16
Pallidum 6 0 8 0 0 0
Putamen 26 20 76 37 60 108
Thalamus proper 335 248 55 54 37 22
Anterior cingulate gyrus 201 163 6 4 0 0
Anterior insula 217 262 84 50 5 2
Anterior orbital gyrus 6 0 13 17 26 6
Angular gyrus 53 164 137 133 0 0
Calc calcarine cortex 3 141 0 83 0 0
Central operculum 204 131 42 40 0 6
Cuneus 0 66 1 68 0 0
Entorhinal area 27 106 13 62 28 0
Frontal operculum 45 55 4 36 0 6
Frontal pole 11 37 77 201 0 0
Fusiform gyrus 87 87 97 115 17 32
Gyrus rectus 78 21 19 28 15 1
Inferior occipital gyrus 118 92 293 139 0 11
Inferior temporal gyrus 328 241 216 197 17 37
Lingual gyrus 0 58 11 167 3 21
Lateral orbital gyrus 56 17 4 6 0 0
Middle cingulate gyrus 17 28 0 27 0 0
Medial frontal cortex 35 27 8 5 0 0
Middle frontal gyrus 85 95 242 221 19 16
Middle occipital gyrus 186 43 169 97 0 42
Medial orbital gyrus 63 51 20 15 30 11
Postcentral gyrus medial segment 0 0 0 0 0 0
Precentral gyrus medial segment 0 0 0 38 0 0
Superior frontal gyrus medial segment 36 131 5 68 0 0
Middle temporal gyrus 703 691 221 335 0 44
Occipital pole 130 152 123 61 0 0
Occipital fusiform gyrus 5 9 5 30 16 20
Opercular part of the inferior frontal gyrus 28 70 71 32 0 33
Orbital part of the inferior frontal gyrus 61 57 0 1 0 0
Posterior cingulate gyrus 0 34 31 39 14 0
Precuneus 1 248 32 230 0 0
Parahippocampal gyrus 3 9 1 27 0 15
Posterior insula 174 159 50 95 65 49
Parietal operculum 110 68 0 0 17 27
Postcentral gyrus 110 0 20 26 0 0
Posterior orbital gyrus 13 41 15 10 0 0
Planum polare 73 7 2 1 8 8
Precentral gyrus 132 5 122 41 0 5
Planum temporale 115 49 3 15 0 12
Subcallosal area 31 33 20 20 0 0
Superior frontal gyrus 6 64 236 248 24 16
Supplementary motor cortex 1 0 16 44 0 0
(Continued)
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TABLE 3 | Continued
Anatomical region CSF patients vs. controls Low Aβ voxel overlap t-tau voxel overlap
Left Right Left Right Left Right
Supramarginal gyrus 308 95 286 112 0 22
Superior occipital gyrus 20 56 108 118 0 0
Superior parietal lobule 0 84 132 128 0 0
Superior temporal gyrus 409 314 124 239 0 25
Temporal pole 242 124 67 133 14 0
Triangular part of the inferior frontal gyrus 173 72 104 66 0 0
Transverse temporal gyrus 58 47 2 9 0 7
Parietal operculum 0 0 0 0 0 0
As illustrated in Figure 2C and summarized in Table 3, a
regression analysis relating GM areas to CSF t-tau included left
dorsolateral frontal, left inferior frontal, right inferior frontal,
right dorsolateral frontal, and striatal regions. Figure 2C and
Table 2 show that regions related to CSF t-tau that overlap
with ROIs implicated in narrative organization included left
dorsolateral frontal and left anterolateral temporal areas.
DISCUSSION
Narrative comprehension is essential to safety and quality of life
in LBD (Kempster et al., 2010; Rosenthal et al., 2010). We found
that narrative organization is more impaired in mildly demented
compared to non-demented patients with LBD, emphasizing
their risk for functional impairment. This effect could not be fully
explained by overall dementia severity as measured by MMSE.
Narrative organization was related to dorsolateral and inferior
frontal brain regions as well as anterolateral temporal regions.
These regions were also associated with CSF levels of Aβ and t-
tau, surrogate markers of AD pathology that is often present in
LBD. Although it is beyond the scope of this study to validate
the anatomic distribution of AD-related pathology in LBD, others
have shown Aβ and tau pathology in these frontal and temporal
regions (Irwin et al., 2012a; Howlett et al., 2015). These findings
suggest that narrative comprehension is impaired in LBD, and we
infer from behavioral-MRI-CSF correlations that this deficit may
be due in part to the accumulation of pathologic amyloid and tau
in an anatomic network centered in the frontal lobe. We discuss
these findings below.
Cognitive difficulties are common in LBD (Aarsland et al.,
2003; Emre et al., 2007; Postuma et al., 2015; Weintraub
et al., 2015). While deficits on standard neuropsychological
measures have been demonstrated in these patients (Hessen et al.,
2016), here we focused on functional needs often mediated by
conversational exchanges that are most effective when organized
rather than vague and tangential. Previous work has shown
a deficit in LBD patients’ organization of narrative expression
(Ash et al., 2011), even though these patients are not aphasic.
This deficit was related in part to executive difficulty. In the
present study of narrative comprehension, all materials were
grammatically simple and semantically familiar, suggesting that
a linguistic deficit could not fully explain their impairment,
and motor difficulty was unlikely to have contributed to this
untimed comprehension task. A deficit in ordering events could
not easily explain performance since all event pairs—bothwithin-
cluster and different-cluster—were consecutively ordered with
good accuracy. Nevertheless, we found that mildly demented
LBD patients are more impaired judging events in different
clusters compared to events in the same cluster, consistent with
difficulty appreciating narrative organization.
LBD performance was related to a specific anatomic network
of GM atrophy. Converging evidence from fMRI activation
studies in healthy adults and neuroanatomic regressions in
FTD patients implicated a neural network centered in frontal
cortex for processing narrative organization (Farag et al., 2010).
We extracted ROIs from this study, and found significant
effects relating impaired narrative organization to GM atrophy
in this anatomic network in LBD as well. Other work has
demonstrated the contribution of dorsolateral prefrontal regions
to the organization of complex material (Koechlin and Jubault,
2006) and the role of inferior frontal regions in cognitive control
over linguistic materials (Friederici et al., 2005). Left anterolateral
temporal GM may play a role in language comprehension
(Patterson et al., 2007), and parietal cortex has been implicated
in perspective-taking in Theory of Mind assessments (Saxe
and Kanwisher, 2003). Interference with the functioning of
this anatomic network occurs in other conditions as well such
as frontotemporal degeneration, but this anatomic network
apparently is not degraded in patients with AD (Farag et al.,
2010).
Clinical-pathological studies have related synuclein pathologic
burden to cognitive difficulty in LBD (Howlett et al., 2015).
Moreover, many LBD patients have Aβ and tau pathology that
is seen in AD (Braak and Braak, 1990; Irwin et al., 2012a, 2017).
Lower CSF Aβ has been related to impaired cognition in LBD
(Montine et al., 2010; Siderowf et al., 2010; Gomperts et al., 2013;
Bäckström et al., 2015). Cognitive difficulty in these studies was
judged clinically or based on a non-specific survey of dementia,
but confounds such as age may cloud the interpretation of
the role of CSF analytes in non-specific dementia measures.
Thus, it is crucial to relate CSF analytes such as Aβ to more
detailed measures of cognition such as narrative organization.
Since these cognitive tasks have regional anatomic specificity,
the contribution of CSF analytes to cognition can be validated
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by another measure such as the anatomic distribution of disease
using MRI. Here, we provide converging evidence for the role of
CSF Aβ in narrative organization that is also associated with MRI
atrophy.
We used a validated CSF cutoff of 192 pg/ml (Shaw et al.,
2009) to identify LBD patients with pathologic Aβ accumulation,
and compared atrophy in these patients with GM in LBD with
normal CSF Aβ. Patients with low Aβ had significant narrative
organization difficulty.Moreover, areas of GM atrophy associated
with reduced CSF Aβ overlapped with dorsolateral and inferior
frontal ROIs previously implicated in narrative organization. Aβ
may accumulate in LBD when first presenting clinically and
this may have clinical consequences early in disease and before
dementia (Gomperts et al., 2013; McMillan and Wolk, 2016).
Since Aβ accumulation may contribute to cognitive difficulty in
all disease stages and not exclusively in dementia, and since some
of our non-demented patients had low CSF Aβ, this may explain
in part why we failed to find a correlation between MMSE and
narrative organization.
The relationship between CSF tau and cognition in LBD is
less clear (Hall et al., 2016; Kang et al., 2016; Terrelonge et al.,
2016). We found that t-tau is related to narrative organization
difficulty. Regression showed that GM atrophy related to CSF
t-tau overlapped with frontal and anterolateral temporal ROIs
implicated in narrative organization. Previous inconsistencies
relating tau to cognition may be due in part to a mismatch
between the task assessing cognition and the anatomic focality
of tau accumulation. Another possible confound is the high
correlation between CSF tau and α-syn in LBD (Hall et al., 2016).
This may be due in part to the release of both t-tau and α-
syn in neuronal disease from adjacent axonal and synaptic loci,
respectively, and additional work is needed to determine whether
tau has an independent contribution to cognitive disorders of
LBD. Previous work related p-tau to executive deficits (Hall et al.,
2016), although the present study found only a borderline effect
for p-tau. Additional work is needed to establish the role of
various forms of tau in cognitive difficulty in LBD.
Several shortcomings should be kept in mind when
considering our findings. While we studied a deeply
endophenotyped subset of cases, our cohort was small and
additional work is needed to confirm our findings in a larger
group. We related CSF Aβ and tau levels to anatomic areas
of GM atrophy statistically, and additional work with Aβ and
tau PET radioligands can assess the role of these and other
anatomic regions associated with pathology more directly.
With these caveats in mind, our findings are consistent with
the hypothesis that LBD patients have difficulty appreciating
narrative organization, and this may be due in part to the
accumulation of AD-related Aβ and tau pathology in frontal
brain regions that support narrative organization. Our findings
suggest that narrative comprehension performance may serve as
an inexpensive screen for the presence of Aβ and tau pathology
in LBD, and that disease-modifying treatments for these
pathologies may stabilize or improve performance on important
functional tasks such as narrative comprehension.
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